Neuroendocrine Tumors

Alcohol Use and Carcinoid
Are Carcinoid & Neuroendocrine the Same?
Chemoembolization for Liver Metastases
Chromagranin A Blood Test
Do All Carcinoid Tumors Cause Symptoms
Does Chemoembolization Work?
Family Genetic Testing in the Presence of MEN Syndrome
Finding Expert Care
Interventional Radiology Procedures for Bone Metastases
Is Pregnancy Safe for Women with Carcinoid on Somatostatin (Octreotide)
Neuroendocrine Tumors and Niacin Supplements
Online Resources for Neuroendocrine and Carcinoid Information
Preparation for 5-HIAA Testing
Radioactivity After Nuclear Medicine Tests
Safety After Octreotide Scan
Typical Carcinoid Versus Atypical Carcinoid
Use of Octreoscan in Neuroendocrine Tumor Diagnose and Treatment
What is an MIBG Scan
Which Patients With Neuroendocrine Tumors Should Have Genetic Testing?
Work Up of Suspected Carcinoid Tumor

Everolimus Ups Survival in Carcinoid Syndrome

Nov 29, 2011 - For patients with low- or intermediate-grade advanced neuroendocrine tumors (carcinoids), everolimus plus octreotide long-acting repeatable (LAR) improves progression-free survival versus placebo plus octreotide LAR, according to a study published online

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More